A middle aged man with an unusual cause
of hip and knee pain: a case presentation
David CH Cheung 張志康
HK Pract 2020;42:94-98
Summary
Hypertrophic pulmonary osteoarthropathy (HPOA) is
a rare disease which is seldom seen in the primary
care setting. However it can be diagnosed, if we
pay attention to the history of a patient. This case
presentation is typical of the disease. Early diagnosis
and management may lead to a better clinical
outcome.
摘要
肺性肥大性骨關節病是一種稀有疾病,在基層醫療中少見。但如我們留意病人的病史,它可被診斷出來。本報告陳述一宗典型病例。及早診斷和治理可帶來更佳的臨床效果。
The case
A 63-year-old man with a past medical history
of colonic polyp in 2015, alcoholic liver disease and
hypertension complained of right hip and knee pain
for 6 months. The pain became worse when walking
upstairs and walking for more than 10 minutes on level
ground. There was some slight pain at rest. There was
no history of injury, numbness nor knee swelling.
He was a chronic smoker with 50 pack years of
cigarette smoking. He quitted drinking after he was
diagnosed with alcoholic liver disease. His only long
term medication was amlodipine 5mg daily.
Physical examination found that he walked with an
antalgic gait. There was no hip or knee deformity. His
right hip was non tender on palpation, the active ranges
of motions were full and without pain. However, his
right thigh was tender on palpation, but no swelling was
felt. The right knee was also not tender on palpation,
no effusion or crepitation, and active ranges of motions
were full. X rays of his right hip and right knee were
ordered. Analgesic balm and paracetamol were given as
symptomatic relief.
X-ray of his right hip and knee showed laminated
periosteal reaction along the femoral diaphysis,
proximal tibia and fibula. No displaced fracture or
dislocation was seen. Features were suggestive of
hypertrophic pulmonary osteoarthropathy. (Figures 1a
and 1b)
At the follow-up consultation, the doctor inquired
about his respiratory symptoms. In fact he had
suffered intermittent cough for 6 months. He had
had mild whitish sputum. There was no haemoptysis,
no shortness of breath at rest, no weight loss and no
fever. On physical examination he was not found to be
clinically dyspnoeic. There was no palpable cervical
lymph nodes and auscultation of his chest was clear
with good air entry. However, there were gross finger
clubbing in both hands.
An urgent chest X ray was ordered in view of his
hip and knee X ray findings and a given history of
prolonged cough in a smoker.
The chest X ray report showed a 6.3cm x 6.5cm
spiculated mass the right middle zone, (Figure 2). This
was highly suspicious of malignancy and an urgent
referral was made to the Internal Medicine Specialist
Clinic. CT thorax showed a 8cm right upper lobe mass
extending into his right middle lobe and right lower
lobe with mediastinal lymph node enlargement and
emphysematous changes. Transbronchial biopsy showed
adenocarcinoma. Unfortunately he died of lung cancer
one month later.
Discussion
Hypertrophic pulmonary oeteo-arthropathy is a
group of symptoms that can affect the organs, lungs,
bones and joints. It is also called Bamberger–Marie
syndrome or osteoarthropathia hypertrophicans. HPOA
is a paraneoplastic syndrome most commonly found in
people with non-small cell lung cancer.1
Less than 1% of lung cancer patients develop
HPOA . Men who smoked heavily and who has
advanced lung cancer predominates those with
HPOA.2
The signs of the condition include swelling
of the ends of the fingers (called clubbing), spoonshaped nails and inf lammation,
swelling and pain in
the hands, fingers, knees or ankles. Finger Clubbing
is characterised by bulbous enlargement of termina
segments of the fingers and toes due to proliferation of
subungual connective tissue.3
X ray shows periosteal
thickening occurs along the shafts of long and short
bones, appearing initially in the distal diaphyseal
regions of the long bones.4
The causes of periosteal
reaction are broad; including trauma, infection,
arthritis, tumours, and drug-induced and vascular
entities. In HPOA it typically produces a periosteal
reaction that is symmetrical and widely distributed.
It typically involves the diaphyses of tubular bones,
sparing the ends. It should be associated with finger
clubbing, enlargement of the extremities and swollen
joints.5
HPOA can be confirmed by the use of bone
scintigraphy because of its higher sensitivity to X ray.6
The typical finding is a symmetrical, abnormally high
uptake in the diaphysis and metaphysis of long bones.
Adenocarcinoma of the lung is the most frequent
histological type, followed by squamous cell carcinoma.
Small cell carcinoma is the least frequent type which
is associated with HPOA. 6
Vascular endothelial
growth factor (VEGF) produced by the tumour is a
cytokine which can lead to vascular hyperplasia, new
bone formation and edema. This is suggestive in the
pathogenesis of HPOA.7
Excision of lung cancer with
high levels of VEGF causes a disappearance of the
skeletal abnormalities and reduction in VEGF level.8
The management of HPOA would be to treat the
underlying cause, and the pain will relief itself. As
medical treatment, non-steroidal anti-inflammatory
drugs (NSAIDs) may be helpful for the painful
osteoarthropathy in controlling the symptoms but
treatment with bisphosphonate such as zoledronic acid
would be a better alternative.9
The pain associated with
HPOA can occasionally be disabling and often refractory
to conventional analgesics if the primary cause is not
treated.10 Finally, the survival rates between lung cancer
patients with and without HPOA are similar.11
In this case, our patient presented with hip and
knee pain, which was due to periostitis secondary to
the paraneoplastic effect of his lung carcinoma. Primary
care physicians should always bear in mind the possible
malignant causes of hip and knee pain so that this
important diagnosis would not be missed. The causes
of hip and knee pain are shown in Table 1 and Table 2
respectively.
Conclusion
Lung cancer is becoming commoner nowadays with
an aging population. Although we may just be aware
of the typical symptoms of lung cancer, its presentation
as a paraneoplastic syndrome should not be forgotten.
Clinicians should bear this diagnosis in mind. Once
this condition is suspected a prompt search for lung
cancer must follow.
David CH Cheung, MBBS (HKU), FRACGP, FHKCFP, FHKAM (Family
Medicine)
Resident Specialist,
Department of Family Medicine and Primary Healthcare, Hong Kong West Cluster,
Hospital Authority;
Honorary Assistant Professor,
Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine,
The University of Hong Kong.
Correspondence to:Dr. David CH Cheung, 10 Aberdeen Reservoir Road, Aberdeen,
Hong Kong SAR.
E-mail: cch334@ha.org.hk
References
-
Hypertrophic pulmonary osteoarthropathy. Available from: https://www.
cancerresearchuk.org [accessed 2019 Nov 1.]
-
Ito T, Goto K, Yoh K, et al. Hypertrophic pulmonary osteoarthropathy
as a paraneoplastic manifestation of lung cancer. J Thorac Oncol.
2010;5:976-980.
-
Amrutha M, Rajagopal TP. Hypertrophic osteoarthropathy: uncommon
presentation of lung cancer. Cleve Clin J Med. 2017;84:270-272
-
Yap FY, Skalski MR, Patel DB, et al. Hypertrophic osteoarthropathy:
clinical and imaging features. Radiographics. 2017 Jan-Feb;37(1):157-195.
doi: 10.1148/rg.2017160052
-
Rana RS, Wu JS, Eisenberg R L. Per iosteal reaction. AJR. 2009
October;193:W259-W272.
-
Qian X, Qin J. Hypertrophic pulmonary osteoarthropathy with primary
lung cancer. Oncol Lett. 2014;7:2079-2082.
-
Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A
and platelet-derived growth factor (PDGF) play a central role in the
pathogenesis of digital clubbing. J Pathol. 2004;203:721-728.
-
Ola´n F, Portela M, Navarro C, et al. Circulating vascular endothelial
growth factor concentrations in a case of pulmonary hypertrophic
osteoarthropathy. Correlation with disease activity. J Rheumatol.
2004;31:614-616.
-
Jayakar BA , Abelson AG , Yao Q. Treatment of hypertrophic
osteoarthropathy with zoledronic acid: case report and review of the
literature. Semin Arthritis Rheum. 2011 Oct;41(2):291-296.
-
Ng uyen S, Hojjati M. Review of cur rent therapies for secondar
yhyper trophic pulmonar y osteoar thropathy. Clin Rheumatol. 2011
Jan;30(1):7-13.
-
Morgan B, Coakley F, Finlay DB, et al. Hypertrophic osteoarthropathy
in staging skeletal scintigraphy for lung cancer. Clin Radiol.
1996;51(10):694-697.
-
Braun P. Hip pain. Australian Family Physician. 2007 Jun;36(6):406-413.
-
Ringdahl E, Pandit S. Treatment of k nee osteoar thritis. Am Fam
Physician. 2011 Jun 1;83(11):1287-1292.
|